on January 18, 2013 |
Permalink
Topics: Strategy, Service Lines, Finance, Capital Planning, Neurosciences, Sleep, Stroke, Spine
Ashley Ford
Now that we are nearly a month into 2013, it’s time to reset our horizon scanning efforts and prepare ourselves for the year ahead. Last year was exciting for the neurosciences community. Several artificial discs and stroke devices were approved by the FDA, the debate about the efficacy of spine surgery continued, and new criteria for comprehensive stroke center certification was released.
It’s easy to imagine that 2013 will come with a host of new technological and programmatic developments across the year. To help understand the evolving product pipeline in neurosciences and spine, I've outlined what we believe are the top six technological trends to watch for across 2013.
You'll hear it first from our bloggers throughout 2013—subscribe now to receive updates right to your inbox.
Continue reading:
What to watch for in neurosciences in 2013: New devices target specialized conditions
on November 29, 2012 |
Permalink
Topics: Service Lines, Imaging, Clinical Technology, Clinical Research, Finance, Capital Planning
Christopher Pericak and Matthew Morrill
How can the imaging business do more with less? This question has become somewhat of a cliché over the past four years, but maintains its relevancy as providers prepare for payment reform. However large the hurdles might seem that hospitals and health systems face, RSNA's vendor floors are overflowing with options to maintain or improve quality at a lower cost here in Chicago.
Continue reading:
RSNA 2012 day three: How can the imaging business do more with less?
on November 28, 2012 |
Permalink
| Comments (2)
Topics: Service Lines, Imaging, Clinical Technology, Clinical Research, Finance, Capital Planning
Christopher Pericak and Matthew Morrill
Our second day at RSNA 2012 was full of booth tours and scientific sessions as we continue to report live from the conference. The mood seems different from that of other conferences in the past, as the industry lingers in a transitory period between fee-for-service medicine and accountable care.
As one vendor representative put it, “It’s pretty quiet around here this year. Not much innovation.”
However, we still witnessed a steady flow of radiologists, medical device representatives, and hospital administrators scurrying from scientific sessions to vendor presentations. The truth is that there are over 60,000 people keeping themselves busy at one of the largest medical conferences in the world—and there are plenty of reasons to stay busy.
Continue reading:
RSNA 2012 day two: Where’s the innovation?
